Chimerix, a new antiviral company
Chimerix has quite the antiviral portfolio; HIV, HPV, CMV, and Smallpox.
About
RSS
Subscribe Via RSS
Meta
BioSpace- Women Researchers Less Likely To Receive Major Career Funding Grants, University of Michigan Study Shows
- Trellis Bioscience, Inc. Grants MedImmune License for Its Anti-RSV Antibodies in Deal Worth Potentially $338 Million
- Pfizer Inc. Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
- GlaxoSmithKline Takes 19% of Aspen Pharmacare Ltd. After Completing Deal
- Probiotic Found to Be Effective Treatment for Colitis in Mice, University of California, Los Angeles (UCLA) And Cleveland Clinic Study
- Biosingularity
